Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1985 May;82(9):2970–2974. doi: 10.1073/pnas.82.9.2970

Levels of human and rat hypothalamic growth hormone-releasing factor as determined by specific radioimmunoassay systems.

T Audhya, M M Manzione, T Nakane, N Kanie, J Passarelli, M Russo, C S Hollander
PMCID: PMC397688  PMID: 3921969

Abstract

Polyclonal antibodies to synthetic human pancreatic growth hormone-releasing factor [hpGRF(1-44)NH2] and rat hypothalamic growth hormone-releasing factor [rhGRF(1-43)OH] were produced in rabbits by injecting these weak immunogens, coupled to thyroglobulin and emulsified with complete Freund's adjuvant in the presence of activated charcoal, directly into the spleen. A subsequent booster injection by the conventional intramuscular route resulted in high-titer antibodies, which at a 1:20,000 dilution were used to develop highly sensitive and specific radioimmunoassays for these peptides. By using antibodies with an apparent Ka of 3.3 X 10(-12) (human) and 7.7 X 10(-11) (rat), the sensitivity of these assays in both human and rat was found to be less than 1 fmol. The antibody to hpGRF(1-44)NH2 is directed against the COOH-terminal region of the molecule, as shown by its crossreactivity with various hpGRF analogues: 140% with hpGRF(30-44)NH2; 1%-2% with hpGRF(1-37)OH, hpGRF(1-40)OH, and hpGRF(1-40)NH2; and none with hpGRF(1-29)NH2. Serial dilutions of human and rat hypothalamic extracts demonstrated parallelism with the corresponding species-specific standard and 125I-labeled tracer. There was no crossreactivity with other neuropeptides, gastrointestinal peptides, or hypothalamic extracts of other species. The hypothalamic content in fmol/mg (wet weight) of tissue was 3.6 +/- 0.2 for the human and 11.1 +/- 5.5 for the rat. Age-related changes in hypothalamic GRF content were present in rats, with a gradual increase from 2 to 16 weeks and a correlation between increasing body weight and GRF content. These radioimmunoassays will serve as important tools for understanding the regulation of growth hormone secretion in both human and rat.

Full text

PDF
2970

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arimura A., Culler M. D., Turkelson C. M., Luciano M. G., Thomas C. R., Obara N., Groot K., Rivier J., Vale W. In vitro pituitary hormone releasing activity of 40 residue human pancreatic tumor growth hormone releasing factor. Peptides. 1983 Jan-Feb;4(1):107–110. doi: 10.1016/0196-9781(83)90175-4. [DOI] [PubMed] [Google Scholar]
  2. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973 Jan 5;179(4068):77–79. doi: 10.1126/science.179.4068.77. [DOI] [PubMed] [Google Scholar]
  3. Böhlen P., Brazeau P., Bloch B., Ling N., Gaillard R., Guillemin R. Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40. Biochem Biophys Res Commun. 1983 Aug 12;114(3):930–936. doi: 10.1016/0006-291x(83)90649-6. [DOI] [PubMed] [Google Scholar]
  4. Böhlen P., Esch F., Brazeau P., Ling N., Guillemin R. Isolation and characterization of the porcine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun. 1983 Oct 31;116(2):726–734. doi: 10.1016/0006-291x(83)90585-5. [DOI] [PubMed] [Google Scholar]
  5. Carlson H. E., Gillin J. C., Gorden P., Snyder F. Abscence of sleep-related growth hormone peaks in aged normal subjects and in acromegaly. J Clin Endocrinol Metab. 1972 Jun;34(6):1102–1105. doi: 10.1210/jcem-34-6-1102. [DOI] [PubMed] [Google Scholar]
  6. Cronin M. J., Rogol A. D., MacLeod R. M., Keefer D. A., Login I. S., Borges J. L., Thorner M. O. Biological activity of a growth hormone-releasing factor secreted by a human tumor. Am J Physiol. 1983 Apr;244(4):E346–E353. doi: 10.1152/ajpendo.1983.244.4.E346. [DOI] [PubMed] [Google Scholar]
  7. DEUBEN R. R., MEITES J. STIMULATION OF PITUITARY GROWTH HORMONE RELEASE BY A HYPOTHALAMIC EXTRACT IN VITRO. Endocrinology. 1964 Mar;74:408–414. doi: 10.1210/endo-74-3-408. [DOI] [PubMed] [Google Scholar]
  8. Esch F. S., Böhlen P., Ling N. C., Brazeau P. E., Wehrenberg W. B., Thorner M. O., Cronin M. J., Guillemin R. Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity. Biochem Biophys Res Commun. 1982 Nov 16;109(1):152–158. doi: 10.1016/0006-291x(82)91578-9. [DOI] [PubMed] [Google Scholar]
  9. Esch F., Böhlen P., Ling N., Brazeau P., Guillemin R. Isolation and characterization of the bovine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun. 1983 Dec 28;117(3):772–779. doi: 10.1016/0006-291x(83)91664-9. [DOI] [PubMed] [Google Scholar]
  10. FRANZ J., HASELBACH C. H., LIBERT O. Studies of the effect of hypothalamic extracts on somatotrophic pituitary function. Acta Endocrinol (Copenh) 1962 Nov;41:336–350. doi: 10.1530/acta.0.0410336. [DOI] [PubMed] [Google Scholar]
  11. Finkelstein J. W., Roffwarg H. P., Boyar R. M., Kream J., Hellman L. Age-related change in the twenty-four-hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab. 1972 Nov;35(5):665–670. doi: 10.1210/jcem-35-5-665. [DOI] [PubMed] [Google Scholar]
  12. Frohman L. A., Szabo M., Berelowitz M., Stachura M. E. Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly. J Clin Invest. 1980 Jan;65(1):43–54. doi: 10.1172/JCI109658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Guillemin R., Brazeau P., Böhlen P., Esch F., Ling N., Wehrenberg W. B. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science. 1982 Nov 5;218(4572):585–587. doi: 10.1126/science.6812220. [DOI] [PubMed] [Google Scholar]
  15. Guillemin R., Zeytin F., Ling N., Böhlen P., Esch F., Brazeau P., Bloch B., Wehrenberg W. B. Growth hormone-releasing factor: chemistry and physiology. Proc Soc Exp Biol Med. 1984 Apr;175(4):407–413. doi: 10.3181/00379727-175-41813. [DOI] [PubMed] [Google Scholar]
  16. Leveston S. A., McKeel D. W., Jr, Buckley P. J., Deschryver K., Greider M. H., Jaffe B. M., Daughaday W. H. Acromegaly and Cushing's syndrome associated with a foregut carcinoid tumor. J Clin Endocrinol Metab. 1981 Oct;53(4):682–689. doi: 10.1210/jcem-53-4-682. [DOI] [PubMed] [Google Scholar]
  17. Martin J. B., Brazeau P., Tannenbaum G. S., Willoughby J. O., Epelbaum J., Terry L. C., Durand D. Neuroendocrine organization of growth hormone regulation. Res Publ Assoc Res Nerv Ment Dis. 1978;56:329–357. [PubMed] [Google Scholar]
  18. Rivier J., Spiess J., Thorner M., Vale W. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature. 1982 Nov 18;300(5889):276–278. doi: 10.1038/300276a0. [DOI] [PubMed] [Google Scholar]
  19. Rodbard D., Frazier G. R. Statistical analysis of radioligand assay data. Methods Enzymol. 1975;37:3–22. doi: 10.1016/s0076-6879(75)37003-1. [DOI] [PubMed] [Google Scholar]
  20. Saeed uz Zafar M., Mellinger R. C., Fine G., Szabo M., Frohman L. A. Acromegaly associated with a bronchial carcinoid tumor: evidence for ectopic production of growth hormone-releasing activity. J Clin Endocrinol Metab. 1979 Jan;48(1):66–71. doi: 10.1210/jcem-48-1-66. [DOI] [PubMed] [Google Scholar]
  21. Saunders A., Terry L. C., Audet J., Brazeau P., Martin J. B. Dynamic studies of growth hormone and prolactin secretion in the female rat. Neuroendocrinology. 1976;21(3):193–203. doi: 10.1159/000122525. [DOI] [PubMed] [Google Scholar]
  22. Schally A. V., Baba Y., Nair R. M., Bennett C. D. The amino acid sequence of a peptide with growth hormone-releasing activity isolated from porcine hypothalamus. J Biol Chem. 1971 Nov;246(21):6647–6650. [PubMed] [Google Scholar]
  23. Sonntag W. E., Steger R. W., Forman L. J., Meites J. Decreased pulsatile release of growth hormone in old male rats. Endocrinology. 1980 Dec;107(6):1875–1879. doi: 10.1210/endo-107-6-1875. [DOI] [PubMed] [Google Scholar]
  24. Spiess J., Rivier J., Thorner M., Vale W. Sequence analysis of a growth hormone releasing factor from a human pancreatic islet tumor. Biochemistry. 1982 Nov 23;21(24):6037–6040. doi: 10.1021/bi00267a002. [DOI] [PubMed] [Google Scholar]
  25. Spiess J., Rivier J., Vale W. Characterization of rat hypothalamic growth hormone-releasing factor. Nature. 1983 Jun 9;303(5917):532–535. doi: 10.1038/303532a0. [DOI] [PubMed] [Google Scholar]
  26. Tatemoto K., Mutt V. Isolation and characterization of the intestinal peptide porcine PHI (PHI-27), a new member of the glucagon--secretin family. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6603–6607. doi: 10.1073/pnas.78.11.6603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Thompsom R. G., Rodriguez A., Kowarski A., Migeon C. J., Blizzard R. M. Integrated concentrations of growth hormone correlated with plasma testosterone and bone age in preadolescent and adolescent males. J Clin Endocrinol Metab. 1972 Aug;35(2):334–337. doi: 10.1210/jcem-35-2-334. [DOI] [PubMed] [Google Scholar]
  28. Thorner M. O., Perryman R. L., Cronin M. J., Rogol A. D., Draznin M., Johanson A., Vale W., Horvath E., Kovacs K. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest. 1982 Nov;70(5):965–977. doi: 10.1172/JCI110708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Thorner M. O., Rivier J., Spiess J., Borges J. L., Vance M. L., Bloom S. R., Rogol A. D., Cronin M. J., Kaiser D. L., Evans W. S. Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man. Lancet. 1983 Jan 1;1(8314-5):24–28. doi: 10.1016/s0140-6736(83)91563-5. [DOI] [PubMed] [Google Scholar]
  30. Wehrenberg W. B., Ling N., Brazeau P., Esch F., Böhlen P., Baird A., Ying S., Guillemin R. Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats. Biochem Biophys Res Commun. 1982 Nov 30;109(2):382–387. doi: 10.1016/0006-291x(82)91732-6. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES